Evidence map›Paper›PMID 33481984›Full record

ArticleInvestigative ophthalmology & visual science2021

Pigment Epithelium-Derived Factor Peptide Promotes Corneal Nerve Regeneration: An In Vivo and In Vitro Study.

Shu-I Yeh, Sung-Hsun Yu, Hsiao-Sang Chu, Chin-Te Huang, Yeou-Ping Tsao, Chao-Min Cheng, Wei-Li Chen

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Delivery Systems of Retinoprotective Proteins in the Retina.International journal of molecular sciences · 2021
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Shu-I YehDepartment of Ophthalmology, Mackay Memorial Hospital, Taipei, Taiwan.
Sung-Hsun YuDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Hsiao-Sang ChuDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Chin-Te HuangDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Yeou-Ping TsaoDepartment of Ophthalmology, Mackay Memorial Hospital, Taipei, Taiwan.
Chao-Min ChengInstitute of Biomedical Engineering, National Tsing Hua University, Hsinchu, Taiwan.
Wei-Li ChenDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
National Taiwan University Hospital · TWMackay Medical College · TWMackay Memorial Hospital · TWNational Taiwan University · TWNational Tsing Hua University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To investigate the potential of a pigment epithelium-derived factor (PEDF) peptide 44-mer to promote nerve regeneration in a rabbit corneal nerve injury model to demonstrate its neurotrophic ability in cultivated mouse trigeminal neuron cells. Methods: Subconjunctival or intrastromal injection of 44-mer on the cornea was performed in a rabbit model of corneal nerve injury created by corneal epithelial debridement. Immunocytochemical analysis (44-mer, anti-tubulin III, SMI312, CD11b, and α-SMA) and in vivo confocal microscopy were performed. Corneal sensation was estimated using a Cochet-Bonnet corneal esthesiometer. Primary cultivated mouse trigeminal neurons were used to examine the in vitro neurotrophic ability of 44-mer. The cellular morphology and the immunocytochemical staining with anti-tubulin III and SMI312 in different concentrations of 44-mer were compared, and a quantitative assessment of neurite outgrowth was performed. Results: Immunohistochemical staining showed the retention of 44-mer in the corneal stroma for at least 7 days after a single dose of corneal intrastromal injection and promoted corneal nerve regeneration revealed by in vivo confocal microscopy. Corneal esthesiometer demonstrated gradual recovery of the corneal sensation in 44-mer-treated eyes with a lower corneal touch threshold than wounded vehicles and closer to baseline at 3 weeks after corneal injury (P < 0.001). In vitro studies showed a dose-dependent neurotrophic effect of 44-mer in cultivated trigeminal neuron cells. Conclusions: The 44-mer showed in vivo and in vitro corneal neurotrophic abilities. Our results suggest that intrastromal injection of 44-mer into the corneal stroma may have a potential role in treating diseases related to corneal nerve damage.

Indexed as

AnimalsCorneaCorneal InjuriesCorneal StromaDisease Models, AnimalDose-Response Relationship, DrugEye ProteinsInjections, IntraocularMicroscopy, ConfocalNerve Growth FactorsNerve RegenerationOphthalmic NervePigment Epithelium-Derived FactorProtease InhibitorsRabbitsSerpinsEye ProteinsNerve Growth FactorsPigment Epithelium-Derived FactorProtease InhibitorsSerpins

Identifiers

PMID33481984
PMCPMC7838554
OpenAlexW3125351137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.